“EVALUATING THE HATCH-WAXMAN AMENDMENT’S INFLUENCE ON FDA’S GENERIC MEDICATION APPROVAL PROCESS”. Journal of Pharmaceutical Negative Results, Oct. 2022, pp. 3393-05, https://doi.org/10.47750/pnr.2022.13.S06.454.